Hydrolysis mechanism of anticancer Pd(II) complexes with coumarin derivatives: a theoretical investigation

被引:21
作者
Alberto, Marta E. [1 ,2 ]
Cosentino, Carlo [1 ,2 ]
Russo, Nino [1 ,2 ]
机构
[1] Univ Calabria, Dipartimento Chim, I-87036 Arcavacata Di Rende, CS, Italy
[2] Univ Calabria, Ctr Eccellenza MIUR, Ctr Calcolo Ad Alte Prestazioni Elaborazioni Para, I-87036 Arcavacata Di Rende, CS, Italy
关键词
Anticancer drugs; Pd(II) complexes; Trans-oriented drugs; CYTOTOXIC ACTIVITY; TRANS GEOMETRY; PLATINUM; PALLADIUM(II); ACTIVATION; DRUGS; CISPLATIN; BINDING;
D O I
10.1007/s11224-011-9927-4
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The hydrolysis reaction mechanisms of a new generation Pd(II) anticancer drugs containing coumarin derivatives have been investigated combining density functional theory with the conductor-like dielectric continuum model approach. The first and the second aquation processes have been explored for the cis and trans counterpart of title PdL2 complex. Two possibilities for the second hydrolysis process have been analyzed for both compounds. From our data emerge that cis and trans PdL2 compounds have a different behavior in water. cis-isomer readily undergo first hydrolysis process generating a mono-aqua complex while both the pathways investigated for the second aquation reaction are more energetically demanding, suggesting that the mono-aqua complex could act as active species. On the contrary, for trans-compound, both the investigated reactions for the second aquation process occur by overcoming activation barriers comparable with that found for the first hydrolysis reaction. According to our data, trans-oriented PdL2 drug could undergo degradation process generating non-active compounds with the consequent lack of pharmacological activity.
引用
收藏
页码:831 / 839
页数:9
相关论文
共 50 条
[41]   On the hydrolysis mechanism of the second-generation anticancer drug carboplatin [J].
Pavelka, Matej ;
Lucas, Maria Fatima A. ;
Russo, Nino .
CHEMISTRY-A EUROPEAN JOURNAL, 2007, 13 (36) :10108-10116
[42]   Activation of anti-cancer drug cisplatin - is the activated complex fully aquated? [J].
Raber, J ;
Zhu, CB ;
Eriksson, LA .
MOLECULAR PHYSICS, 2004, 102 (23-24) :2537-2544
[43]   Medicinal applications of metal complexes binding to biological macromolecules [J].
Reedijk, Jan .
MACROMOLECULAR SYMPOSIA, 2008, 270 :193-201
[44]   PLATINUM COMPOUNDS - A NEW CLASS OF POTENT ANTITUMOUR AGENTS [J].
ROSENBERG, B ;
VANCAMP, L ;
TROSKO, JE ;
MANSOUR, VH .
NATURE, 1969, 222 (5191) :385-+
[45]   INHIBITION OF CELL DIVISION IN ESCHERICHIA COLI BY ELECTROLYSIS PRODUCTS FROM A PLATINUM ELECTRODE [J].
ROSENBERG, B ;
VANCAMP, L ;
KRIGAS, T .
NATURE, 1965, 205 (4972) :698-+
[46]   TRANSITION-STATE ELECTRONIC-STRUCTURES IN SN2 REACTIONS [J].
SHI, Z ;
BOYD, RJ .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1989, 111 (05) :1575-1579
[47]   Towards the rational design of platinum(II) and gold(III) complexes as antitumour agents [J].
Wang, Xiaoyong ;
Guo, Zijian .
DALTON TRANSACTIONS, 2008, (12) :1521-1532
[48]   FT-Raman studies on the transformation of G-actin to F-actin, the binding of cisplatin and transplatin to F-actin and the effects of the conformation of F-actin [J].
Zeng, HH ;
Xu, ZH ;
Wang, K .
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 1997, 20 (02) :107-113
[49]   Hydrolysis theory for cisplatin and its analogues based on density functional studies [J].
Zhang, Y ;
Guo, ZJ ;
You, XZ .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2001, 123 (38) :9378-9387
[50]   Hydrolysis process of the second generation platinum-based anticancer drug cis-amminedichlorocyclohexylamineplatinum(II) [J].
Zhu, CB ;
Raber, J ;
Eriksson, LA .
JOURNAL OF PHYSICAL CHEMISTRY B, 2005, 109 (24) :12195-12205